Available now! Telegram Research 2025 — the year's key insights 
Hidden Multibagger Stocks by Devendra (RA: INH000026488)
Open in Telegram
Disclaimer: I am a SEBI Registered Research Analyst (RA: INH000026488). All stocks, market updates, and investment-related information shared in this channel are strictly for educational and informational purposes only.
Show more9 871
Subscribers
+324 hours
+277 days
+5830 days
Posts Archive
ENVIRO INFRA posted good Q3 result
NET PROFIT AT 37 CR V 17.4 CR YOY
REVENUE AT 247 CR V 150 CR
ENVIRO INFRA Q3 EBITDA AT 54 CR V 27.6 CR YOY
MARGINS AT 21.8 % V 18.4 %
We are currently in a bear phase, and based on chart , the market tends to correct after every small pullback as it searches for a new bottom. The market has not yet formed a clear bottom, and although a reversal may seem to be taking place, as I explained yesterday.
Some people may be upset by my market outlook, but if you truly understand the market, you can take corrective action. Otherwise, overconfidence may lead to increasing losses day by day in a bear phase.
In such a market, taking aggressive positions without proper knowledge can result in being trapped for an extended period. Stock selection during a bear market is extremely challenging, as even technical charts fail to provide reliable breakout signals.
Under these conditions, a short-term approach can work, but only if stocks are selected with precision. Otherwise, the best strategy is to wait and observe until the high volatility subsides.
" BLUE JET HEALTHCARE "healthcare sector stock non stop rally..🚀
" C2C ADVANCED SYSTEM " strong recovery continue..🚀
Here are the major events in the next three days that could impact the stock market:
February 6: The Finance Minister is set to introduce a new Income Tax Bill in Parliament today. Let's hope for a favorable bill.
February 7: The Reserve Bank of India (RBI) will hold its monetary policy meeting tomorrow.
February 8: The results of the Delhi Assembly elections will be announced.
These events could influence market sentiment and volatility.
These 2 Ashish Kacholia portfolio stocks hit new highs; jumped up to 7% | News on Markets - Business Standard
https://www.business-standard.com/markets/news/these-2-ashish-kacholia-portfolio-stocks-hit-new-highs-jumped-up-to-7-125020500893_1.html
" Innova Captab " posted good Q3 result..
FII selling continues, but the US 10-year bond yield has started to decline from 4.5% to 4.4%. This drop in bond yields is expected to reduce heavy FII selling. However, while FIIs may continue selling, it will likely be in smaller quantities, which could help the Indian market perform better.
If the US bond yield falls further below 4.3%, FIIs may start buying again. At the current level of 4.4%, they are unlikely to sell aggressively, which is a positive sign for the market. However, any rise in bond yields could change this scenario.
Investors who are waiting to buy should consider investing in stocks with strong Q3 results, as such stocks offer better protection against potential market downturns.
Pharma stocks have shown good movement today as well. In a bear phase, the best strategy is to book regular profits, as highly volatile markets do not typically yield multibagger returns. During such phases, panic selling by retail investors can wipe out gains in just a day or two.
" Artemis Medicare " Posted good Q3 result...
The US 10-year bond yield has broken below the 4.5% level and continues to decline. If bond yields fall further, we can expect increased FII inflows into the Indian market. This could lead to further upside, particularly in sectors that benefit from strong liquidity, such as banking, infrastructure, and midcap stocks.
In the current bear phase, Nifty may reach a maximum level of 23,800 to 24,000, from where a market reversal could be expected. The current pullback is a result of oversold conditions. This prediction is based on the fact that the US 10-year bond yield remains at an elevated level.
" Supriya Lifescience " Again hit all time high..🚀🚀
PHARMA STOCKS : US tariff across China Inc pharma Could lead to shortages, higher prices & USFDA clearing Indian plants faster..
Eris life
Markshan pharma
Bliss GVS
Venus Remedies
Jubilant pharmova
Stride pharma
This information is only for education purpose..
" Jubilant pharmova " Strong recovery after long consolidation...Posted very good Q3 result..🚀🚀
" Epigral ltd " strong recovery after long consolidation..🚀
